(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Name | 2022 Bonus | ||||
Dr. Kang Sun | $370,875 | ||||
Sandra Wallach | $155,756 | ||||
Dr. Ionel Stefan | $150,075 |
Name | Base Salary, Effective 1/1/2023 | Target Annual Bonus (% of Base Salary), Effective 1/1/2023 | ||||||
Dr. Kang Sun | $624,000 | 100% | ||||||
Sandra Wallach | $373,000 | 65% | ||||||
Dr. Ionel Stefan | $364,000 | 60% |
AMPRIUS TECHNOLOGIES, INC. | ||||||||
Date: January 12, 2023 | By: | /s/ Sandra Wallach | ||||||
Name: Sandra Wallach | ||||||||
Title: Chief Financial Officer |
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end
DBURG3:TO,# X>\1-O#MA]_6\Z7O+/Z4H
M?W0&9Z1 V% *:/XH#TC@-E#HCI9?QJ!V%QF-6!Y%!]X:,T<+N!!@GE:V;
M5=WTHO3+MN/ZHNJ:J^/:^5QD/$C&HRR1=V RLV!8B-YI@ZUBPD:W)N#DR4X,
MPH;M&3;3R;X3%+TM2O_[19]D.XRU,-:#%SY-F_$78(Q6@ FE&;&.,^,F0.:[
MQ4%\\#WC8T-!=P*&,[T^<5&6(A37SVMN'-$>*8R9!6I85$0F173*KU2F+4,J
M$V;KC[!D FK60--.]"
MZ9#""T*YL% "F*DP4& 8IV>8 J8\-S+<%#SM?=%3ED?$>^]HQ4_U^?)Z7;1Y9A6BR(48]3(>)R(9$&'Z'J;LBL-,$FW%<[VX5ZWN
M86TM;:+#E5V[NW,7)M\5,V*L/'/DY;NQ
?
M]74TTV'@H=#KX56^6\".]7!/^;4="L:S-LU8X$"8>WE!OYS"N4Z
MTNNLENMJ/[J8?K>VFW%.I821N;7GY2M?. %,0A\P'$88<>S'5#B6T?^5"NB/
M4CD_JF;^+U(M?_(R^1,5R,^A-'Y84?R0